Hodgkin’s disease is an extremely rare type of lymphoma, accounting for less than 1 percent of all cancers diagnosed in the United States. Like other lymphomas, it originates in the lymphatic system, part of the body’s immune system. Hodgkin’s disease is more common in men than in women, and it occurs most often in people between the ages of 15 and 34 or over 55.
At Ohio State's Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute we have a team of physicians and physician-researchers who specialize in detecting and treating Hodgkin’s disease. With research and treatment areas under one roof, we are better able to translate research advances to patient care – so our team of specialists can provide the best possible care for patients with Hodgkin’s disease.
As one of only four institutions approved by the National Cancer Institute (NCI) to conduct phase I and II clinical trials on NCI sponsored anticancer agents, the OSUCCC – James has access to more leading-edge targeted cancer therapies than most hospitals across America. That translates to better outcomes, fewer side effects and more hope.Search open cancer clinical trials.
This section of the Web site will give you access to:
If you have questions about Hodgkin's disease, please call The James Line – a free cancer information resource and physician referral service – at 614-293-5066 or 1-800-293-5066 (outside Franklin County) or e-mail now. The James Line oncology nurses can
be reached Monday-Friday 8:00 a.m.-5:00 p.m. (except weekends and